Canandaigua National Corp’s Thermo Fisher Scientific TMO Stock Holding History

Canandaigua National Corp’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.17M	Buy	+4,415	New	+$2.4M	0.19%	104
2022 Q4	$5.87M	Buy	10,667 +2,492	+30%	+$1.32M	1%	26
2022 Q3	$4.15M	Sell	8,175 -40	-0.5%	-$22.4K	0.74%	36
2022 Q2	$4.46M	Sell	8,215 -879	-10%	-$484K	0.79%	35
2022 Q1	$5.37M	Sell	9,094 -96	-1%	-$55.1K	0.82%	35
2021 Q4	$6.13M	Buy	9,190 +458	+5%	+$286K	0.91%	31
2021 Q3	$4.99M	Sell	8,732 -134	-2%	-$73.5K	0.81%	39
2021 Q2	$4.47M	Buy	8,866 +545	+7%	+$257K	0.73%	44
2021 Q1	$3.8M	Sell	8,321 -199	-2%	-$95K	0.64%	50
2020 Q4	$3.97M	Buy	8,520 +1,027	+14%	+$482K	0.7%	42
2020 Q3	$3.31M	Sell	7,493 -66	-0.9%	-$27.3K	0.58%	54
2020 Q2	$2.74M	Buy	+7,559	New	+$2.53M	0.5%	62

Other funds holding TMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Canandaigua National Corp's TMO Position: Q1 2026 in Review

Canandaigua National Corp opened a new position in Thermo Fisher Scientific (TMO) in Q1 2026: 4,415 shares worth $2.17M. The stake represents 0.19% of the portfolio and ranks #104 among its holdings. This is a return to the name: Canandaigua National Corp previously reported a position in TMO as recently as Q4 2022.

Canandaigua National Corp first reported a position in TMO in Q2 2020 and has held it in 12 quarters since. The position peaked at $6.13M in Q4 2021. 2,590 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

Canandaigua National Corp held 4,415 shares of Thermo Fisher Scientific worth $2.17M as of Q1 2026.
Thermo Fisher Scientific was a new Canandaigua National Corp position in Q1 2026.
Thermo Fisher Scientific made up 0.19% of Canandaigua National Corp's portfolio in Q1 2026, its #104 holding.
Canandaigua National Corp first reported a position in Thermo Fisher Scientific in Q2 2020 and has held it in 12 quarters since.
Canandaigua National Corp's Thermo Fisher Scientific position peaked at $6.13M in Q4 2021.
2,590 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Canandaigua National Corp's 13F filing for Q1 2026, filed 8 Apr 2026.